Global Benchmark for Efficient Drug Pricing (GLOBE) Model

The Centers for Medicare & Medicaid Services has finalized the Global Benchmark for Efficient Drug Pricing (GLOBE) Model, a mandatory payment model under Section 1115A of the Social Security Act. The model tests an alternative approach to calculating Medicare Part B drug inflation rebate amounts for certain separately billed drugs and biologics in traditional Medicare. Its goal is to lower drug costs for fee-for-service beneficiaries and the broader Medicare program while maintaining care quality.

Read full article at Federal Register ↗

About this summary. The text above is a short summary written for this site. The original article is hosted by Federal Register at the link above; this site does not reproduce the full article. Verify against the source before relying on specific details.